Sacchi M, Tomaselli D, Ruggeri M, Aiello F, Sabella P, Dore S
Int J Mol Sci. 2025; 26(5).
PMID: 40076946
PMC: 11900438.
DOI: 10.3390/ijms26052327.
Lin H, Wang X, Chung M, Cai S, Pan Y
J Transl Med. 2025; 23(1):240.
PMID: 40016790
PMC: 11869441.
DOI: 10.1186/s12967-024-06060-3.
Qiao Y, Liang J, Jiang D
J Respir Biol Transl Med. 2025; 2(1).
PMID: 39925974
PMC: 11800322.
DOI: 10.70322/jrbtm.2024.10023.
Yu Y, Fang J, Li Y, Wang X, Zhang J, Wang J
Nutrients. 2025; 17(1.
PMID: 39796631
PMC: 11723014.
DOI: 10.3390/nu17010197.
Ma X, Liu B, Jiang Z, Rao Z, Zheng L
Int J Mol Sci. 2025; 26(1.
PMID: 39796197
PMC: 11720236.
DOI: 10.3390/ijms26010343.
The potential therapeutic role of melatonin in organ fibrosis: a comprehensive review.
Huang W, Zheng J, Wang M, Du L, Bai L, Tang H
Front Med (Lausanne). 2024; 11:1502368.
PMID: 39735699
PMC: 11681627.
DOI: 10.3389/fmed.2024.1502368.
Molecular Mechanisms of Fibrosis in Cholestatic Liver Diseases and Regenerative Medicine-Based Therapies.
Wang W, Lian H, Liang Y, Ye Y, Tam P, Chen Y
Cells. 2024; 13(23).
PMID: 39682745
PMC: 11640075.
DOI: 10.3390/cells13231997.
The Macrophage-Fibroblast Dipole in the Context of Cardiac Repair and Fibrosis.
Psarras S
Biomolecules. 2024; 14(11).
PMID: 39595580
PMC: 11591949.
DOI: 10.3390/biom14111403.
Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target.
Zhang H, Thai P, Shivnaraine R, Ren L, Wu X, Siepe D
Cell. 2024; 187(25):7143-7163.e22.
PMID: 39413786
PMC: 11645214.
DOI: 10.1016/j.cell.2024.09.034.
Repair and regeneration: ferroptosis in the process of remodeling and fibrosis in impaired organs.
Yin J, Xu X, Guo Y, Sun C, Yang Y, Liu H
Cell Death Discov. 2024; 10(1):424.
PMID: 39358326
PMC: 11447141.
DOI: 10.1038/s41420-024-02181-2.
BRD4: an effective target for organ fibrosis.
Wei Q, Gan C, Sun M, Xie Y, Liu H, Xue T
Biomark Res. 2024; 12(1):92.
PMID: 39215370
PMC: 11365212.
DOI: 10.1186/s40364-024-00641-6.
Emerging role of BMPs/BMPR2 signaling pathway in treatment for pulmonary fibrosis.
Ye Q, Taleb S, Zhao J, Zhao Y
Biomed Pharmacother. 2024; 178:117178.
PMID: 39142248
PMC: 11364484.
DOI: 10.1016/j.biopha.2024.117178.
Regulation of myofibroblast dedifferentiation in pulmonary fibrosis.
Ju X, Wang K, Wang C, Zeng C, Wang Y, Yu J
Respir Res. 2024; 25(1):284.
PMID: 39026235
PMC: 11264880.
DOI: 10.1186/s12931-024-02898-9.
TGF-β1 induces formation of TSG-6-enriched extracellular vesicles in fibroblasts which can prevent myofibroblast transformation by modulating Erk1/2 phosphorylation.
Ilg M, Bustin S, Ralph D, Cellek S
Sci Rep. 2024; 14(1):12389.
PMID: 38811625
PMC: 11136978.
DOI: 10.1038/s41598-024-62123-x.
Macrophages modulate fibrosis during newt lens regeneration.
Tsissios G, Sallese A, Perez-Estrada J, Tangeman J, Chen W, Smucker B
Stem Cell Res Ther. 2024; 15(1):141.
PMID: 38745238
PMC: 11094960.
DOI: 10.1186/s13287-024-03740-1.
Development of a high throughput system to screen compounds that revert the activated hepatic stellate cells to a quiescent-like state.
Nakano Y, Saijou E, Itoh T, Tanaka M, Miyajima A, Kido T
Sci Rep. 2024; 14(1):8536.
PMID: 38609454
PMC: 11014936.
DOI: 10.1038/s41598-024-58989-6.
Targeting the nuclear long noncoding transcript LSP1P5 abrogates extracellular matrix deposition by trans-upregulating CEBPA in keloids.
Gu S, Huang X, Luo S, Liu Y, Khoong Y, Liang H
Mol Ther. 2024; 32(6):1984-1999.
PMID: 38553852
PMC: 11184311.
DOI: 10.1016/j.ymthe.2024.03.031.
Molecular Imaging of Fibrosis in Benign Diseases: An Overview of the State of the Art.
Zhang Y, Huang W, Jiao H, Song L, Kang L
Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543082
PMC: 10974017.
DOI: 10.3390/ph17030296.
Tissue fibrosis associated depletion of lipid-filled cells.
Jussila A, Zhang B, Kirti S, Atit R
Exp Dermatol. 2024; 33(3):e15054.
PMID: 38519432
PMC: 10977660.
DOI: 10.1111/exd.15054.
Factors Affecting the Evaluation of Collagen Deposition and Fibrosis .
Fathi P, Sundaresan V, Alfonso A, Rama Varma A, Sadtler K
Tissue Eng Part A. 2024; 30(9-10):367-380.
PMID: 38511512
PMC: 11250831.
DOI: 10.1089/ten.TEA.2023.0284.